Total Payments
$31,195
2024 Payments
$388.25
Companies
37
Transactions
134
Medicare Patients
13,169
Medicare Billing
$6.6M
Payment Breakdown by Category
Consulting$18,593 (59.6%)
Other$8,000 (25.6%)
Travel$2,330 (7.5%)
Food & Beverage$2,190 (7.0%)
Education$82.90 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,593 | 5 | 59.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,000 | 11 | 25.6% |
| Travel and Lodging | $2,330 | 5 | 7.5% |
| Food and Beverage | $2,190 | 108 | 7.0% |
| Education | $82.90 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $27,268 | 36 | $0 (2024) |
| RefleXion Medical, Inc. | $2,160 | 4 | $0 (2022) |
| Pharmacyclics LLC, An AbbVie Company | $208.45 | 9 | $0 (2023) |
| Daiichi Sankyo Inc. | $140.64 | 5 | $0 (2024) |
| Celgene Corporation | $131.45 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $130.10 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $117.33 | 6 | $0 (2022) |
| Boston Scientific Corporation | $115.92 | 1 | $0 (2023) |
| Amgen Inc. | $89.33 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $84.19 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $388.25 | 9 | AstraZeneca Pharmaceuticals LP ($215.16) |
| 2023 | $172.68 | 3 | Boston Scientific Corporation ($115.92) |
| 2022 | $2,298 | 10 | RefleXion Medical, Inc. ($2,160) |
| 2021 | $13,327 | 15 | AstraZeneca Pharmaceuticals LP ($13,210) |
| 2020 | $8,480 | 12 | AstraZeneca Pharmaceuticals LP ($8,430) |
| 2019 | $5,658 | 28 | AstraZeneca Pharmaceuticals LP ($5,309) |
| 2018 | $403.27 | 26 | Amgen Inc. ($48.20) |
| 2017 | $467.24 | 31 | Celgene Corporation ($74.54) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $132.80 | General |
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $82.36 | General |
| Category: Oncology | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Oncology | ||||||
| 05/07/2024 | Janssen Pharmaceuticals, Inc | RYBREVANT (Drug) | Education | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 04/29/2024 | Janssen Pharmaceuticals, Inc | RYBREVANT (Drug) | Education | In-kind items and services | $22.00 | General |
| Category: Oncology | ||||||
| 04/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/19/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/14/2023 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $115.92 | General |
| Category: Axios_ENDO | ||||||
| 10/17/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2022 | Acrotech Biopharma LLC | FOLOTYN (Drug), BELEODAQ | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Oncology | ||||||
| 06/16/2022 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $32.00 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 06/08/2022 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $35.00 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 05/30/2022 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $538.00 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 05/19/2022 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Travel and Lodging | In-kind items and services | $1,554.80 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 05/12/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: ONCOLOGY | ||||||
| 04/13/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Oncology | ||||||
| 12/01/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| Category: Oncology | ||||||
| 11/10/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 2,991 | 102,827 | $3.8M | $1.5M |
| 2022 | 71 | 3,369 | 111,587 | $4.3M | $1.7M |
| 2021 | 71 | 3,351 | 125,574 | $4.2M | $1.6M |
| 2020 | 75 | 3,458 | 135,480 | $4.6M | $1.9M |
Total Patients
13,169
Total Services
475,468
Medicare Billing
$6.6M
Procedure Codes
279
All Medicare Procedures & Services
279 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 21 | 18,000 | $1.7M | $777,780 | 46.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 69 | 11,400 | $452,700 | $210,164 | 46.4% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 16 | 2,790 | $226,230 | $99,689 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 293 | 981 | $369,837 | $93,036 | 25.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 121 | 437 | $238,169 | $44,836 | 18.8% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 41 | 45,750 | $137,250 | $40,016 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 235 | $124,785 | $31,661 | 25.4% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 29 | 70 | $69,580 | $25,112 | 36.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 121 | $53,648 | $16,135 | 30.1% |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | Office | 2023 | 13 | 58 | $15,950 | $12,118 | 76.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 108 | 243 | $64,567 | $12,041 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $32,550 | $8,257 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 113 | $30,171 | $7,365 | 24.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 209 | 687 | $14,427 | $7,091 | 49.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 96 | 525 | $34,277 | $6,403 | 18.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 217 | 744 | $11,160 | $5,648 | 50.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 39 | 208 | $37,955 | $5,308 | 14.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 36 | 98 | $25,724 | $5,050 | 19.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 198 | 570 | $5,152 | $4,775 | 92.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 134 | 340 | $27,096 | $3,691 | 13.6% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 24 | 80 | $18,751 | $3,554 | 19.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 49 | 57 | $9,159 | $3,533 | 38.6% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 13 | 35 | $12,771 | $2,526 | 19.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 45 | 109 | $12,827 | $2,514 | 19.6% |
| J0640 | Injection, leucovorin calcium, per 50 mg | Office | 2023 | 12 | 697 | $8,713 | $2,404 | 27.6% |
About Dr. Devon Evans, MD
Dr. Devon Evans, MD is a Hematology & Oncology healthcare provider based in Westbrook, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518183532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devon Evans, MD has received a total of $31,195 in payments from pharmaceutical and medical device companies, with $388.25 received in 2024. These payments were reported across 134 transactions from 37 companies. The most common payment nature is "Consulting Fee" ($18,593).
As a Medicare-enrolled provider, Evans has provided services to 13,169 Medicare beneficiaries, totaling 475,468 services with total Medicare billing of $6.6M. Data is available for 4 years (2020–2023), covering 279 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Westbrook, ME
- Active Since 04/18/2007
- Last Updated 04/28/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1518183532
Products in Payments
- IMFINZI (Biological) $10,710
- TAGRISSO (Drug) $9,389
- IMFINZI (Drug) $7,000
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $2,160
- IMBRUVICA (Drug) $175.31
- Axios (Device) $115.92
- INJECTAFER (Drug) $90.15
- Imbruvica (Drug) $76.67
- OPDIVO (Biological) $69.87
- DARZALEX (Biological) $59.65
- ADCETRIS (Biological) $55.54
- Enhertu (Drug) $50.49
- Revlimid (Drug) $44.55
- RYBREVANT (Drug) $44.00
- JAKAFI (Drug) $43.57
- Abraxane (Drug) $41.66
- Lenvima (Drug) $40.42
- Tavalisse (Drug) $39.73
- FASLODEX (Drug) $35.17
- EPKINLY (Drug) $33.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Westbrook
Dr. Matthew Dugan, D.o, D.O
Hematology & Oncology — Payments: $766,946
Hematology & Oncology $766,946
Dr. John Winters, Md, MD
Hematology & Oncology — Payments: $458,775
Hematology & Oncology $458,775
Dr. Eleni Nackos, Md, MD
Hematology & Oncology — Payments: $105,209
Hematology & Oncology $105,209
Dr. Christian Thomas, Md, MD
Hematology & Oncology — Payments: $66,754
Hematology & Oncology $66,754
Dr. Tracey Weisberg, Md, MD
Hematology & Oncology — Payments: $31,532
Hematology & Oncology $31,532
Dr. Daniel Rausch, Md, MD
Hematology & Oncology — Payments: $27,394
Hematology & Oncology $27,394